Nuclear medicine and theranostics

Innovating to cure: a decisive breakthrough against prostate cancer

Prostate cancer, the most common cancer in men, reaches a devastating stage in its metastatic form. A revolution is underway: Targeted Internal Radiotherapy (TIRT), an innovative and targeted technique, offers new perspectives by delivering a dose of radiotherapy directly to the heart of cancer cells. More precise and less toxic, TIRT is transforming the prognosis for patients for whom conventional treatments are ineffective.

The Caen Normandy University Hospital on the front line

By 2025, the University Hospital will position itself as a major player in IVR (Intravenous Radiology), with the ambition of making this technology accessible to a greater number of patients. The Nuclear Medicine and Theranostics Department is investing in cutting-edge solutions to offer personalized and innovative treatments. Among these advancements, the acquisition of a self-shielded injector will be essential to guarantee safe care, protecting both patients and healthcare professionals.

The Theranojet: an essential tool for safe and effective care

The Theranojet is an innovative device designed to safely prepare and administer targeted radiotherapy.

A reference center by 2027

With the opening of the new Caen University Hospital, this technology can be deployed on a large scale, positioning the institution as a center of excellence. This project, which offers hope to thousands of patients, relies on the support of committed donors.

Together, let's build the future of medicine and pave the way for innovative treatments.

We need you!

The acquisition of the Theranojet represents a major step forward for the nuclear medicine and theranostics department at Caen University Hospital. Its use will improve patient care by reducing risks and promoting faster recovery. This innovative technology will benefit more than 50 patients per year.